[1]林玲,曾菁莘,张锡宝,等.miR-148a-3p对银屑病患者Th细胞活化调控的影响[J].中国皮肤性病学杂志,2020,(07):743-747.[doi:10.13735/j.cjdv.1001-7089.201910028]
 LIN Ling,ZENG Jingxin,ZHANG Xinbao,et al.Effects of miR-148a-3p on the Regulation of Th Cell Activation in Patients with Psoriasis[J].The Chinese Journal of Dermatovenereology,2020,(07):743-747.[doi:10.13735/j.cjdv.1001-7089.201910028]
点击复制

miR-148a-3p对银屑病患者Th细胞活化调控的影响
分享到:

《中国皮肤性病学杂志》[ISSN:1001-7089/CN:61-1197/R]

卷:
期数:
2020年07期
页码:
743-747
栏目:
论著
出版日期:
2020-07-01

文章信息/Info

Title:
Effects of miR-148a-3p on the Regulation of Th Cell Activation in Patients with Psoriasis
文章编号:
1001-7089(2020)07-0743-05
作者:
林玲1曾菁莘2张锡宝1罗权1
1.广州市皮肤病防治所,广东 广州 510095; 2.广东省第二人民医院,广东 广州 510317
Author(s):
LIN Ling1ZENG Jingxin2ZHANG Xinbao1LUO Quan1
(1.Department of Dermatology,Guangzhou Institute of Dermatology,Guangzhou 510095,China; 2.Department of Dermatology,Guangdong No.2 Provincial People's Hospital,Affiliated to Southern Medical University,Guangzhou 510317,China)
关键词:
寻常性银屑病 miR-148a-3p CD4+T细胞 Bim蛋白
Keywords:
Psoriasis vulgaris microRNA-148a-3p CD4+T lymphoeytes Bim protein
分类号:
R 758.63
DOI:
10.13735/j.cjdv.1001-7089.201910028
文献标志码:
A
摘要:
目的 在前期研究的基础上进一步验证miR-148a-3p通过促凋亡蛋白Bim对银屑病发病机制中T细胞亚群分化的影响及相关免疫应答机制的调控。方法 培养人T淋巴白血病(Jurkat)细胞; Bim siRNA、miR-148a-3p mimics、miR-148a-3p inhibitor,分别电转CD4+T细胞,RT-qPCR检测miR-148a-3p和Bim mRNA,Western blot检测 Bim 蛋白; 通过ELISA检测培养上清中细胞因子含量。结果 Bim siRNA、miR-148a-3p mimics、miR-148a-3p inhibitor分别电转CD4+T细胞(Jurkat细胞),电转效率可达84.5%。与空白组相比,过表达的miR-148a-3p可有效抑制靶基因Bim mRNA及其蛋白的表达,ELISA检测培养上清中IFN-γ及IL-17均明显升高,IL-4及IL-10均明显降低(P均<0.05); 而抑制miR-148a-3p时Bim mRNA及其蛋白的表达升高,IFN-γ明显减少(P均<0.05),而IL-17表达(P>0.05)下降不明显,IL-4及IL-10均明显升高(P均<0.05)。在正常CD4+T细胞中沉默Bim的表达,IFN-γ及IL-17亦显著升高(P均<0.05)。结论 在银屑病患者中高表达的miR-148a-3p靶向调控Bim的表达可导致Th1、Th17细胞异常活化,Th2细胞数量减少及Treg细胞免疫抑制功能减弱,这提示miR-148a-3p参与寻常性银屑病病情的发生发展,为后续miR-148a-3p靶向干预寻常性银屑病病情提供了依据。
Abstract:
Objective On the basis of previous studies,the effect of miR-148a-3p on the differentiation of T cell subsets in the pathogenesis of psoriasis and the regulation of related immune response were further verified by the proapoptotic protein Bim.Methods Cultured human T lymphoblastic leukemia(Jurkat)cells; Bim siRNA,miR-148a-3p mimics,miR-148a-3p inhibitor,respectively,electroporated CD4+ T cells,RT-qPCR detection of miR-148a-3p and Bim mRNA,Western blot detection Bim protein; cytokine content in culture supernatant was determined by ELISA.Results Bim siRNA,miR-148a-3p mimics and miR-148a-3p inhibitor electroporated CD4+ T cells(Jurkat cells),respectively,and the electrotransfer efficiency was 84.5%.Compared with the blank group,over-expressed miR-148a-3p could effectively inhibit the expression of the target gene Bim mRNA and its protein.IFN-γ and IL-17 were significantly increased in the culture supernatant,while IL-4 and IL-10 were significantly decreased(P<0.05). The expression of Bim mRNA and its protein was increased when miR-148a-3p was inhibited,IFN-γ was significantly decreased(P<0.05),IL-17 was expressed(P>0.05),and IL-4 and IL-10 were significantly increased(P<0.05).The expression of Bim was silenced in normal CD4+ T cells,and IFN-γ and IL-17 were also significantly increased(P<0.05).Conclusion The high expression of miR-148a-3p in patients with psoriasis can regulate the expression of Bim,which leads to the abnormal activation of Th1 and Th17 cells,the decrease of Th2 cell number and the weakening of Treg cell immunosuppression,suggesting that miR-148a-3p is involved in vulgaris.The results provide a basis for subsequent miR-148a-3p targeted intervention for psoriasis vulgaris.

参考文献/References:

[1] Lebwohl M.Psoriasis[J].Ann Intern Med,2018,168(7):ITC49-ITC64.
[2] Sun L,Zhang X.The immunological and genetic aspects in psoriasis[J].Applied Informatics,2014,1(1):3.
[3] Paladini L,Fabris L,Bottai G,et al.Targeting microRNAs as key modulators of tumor immune response[J].J Exp Clin Cancer Res,2016,35:103.
[4] Pan W,Zhu S,Yuan M,et al.MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1[J].J Immunol,2010,184(12):6773.
[5] 曾菁莘,田歆,张锡宝,等.微小RNA-148a-3p在寻常性银屑病患者外周血CD4+ T淋巴细胞中的表达及临床意义[J].中华皮肤科杂志,2019,52(4):231-235.
[6] De Masson A,Bouaziz JD,Battistella M,et al.Immunopathology of psoriasis: from bench to bedside[J].Med Sci,2016,32(3):253-259.
[7] Marco D,Gianfranco A,Eva R.T helpercell subsets in clinical manifestations of psoriasis[J].J Immunol Res,2016,2016:1-7.

相似文献/References:

[1]刘玉林,刘春,张娟.自拟凉血润燥汤治疗血热风燥型寻常性银屑病95例临床观察[J].中国皮肤性病学杂志,2015,(08):853.[doi:10.13735/j.cjdv.1001-7089.201411143]
 LIU Yu lin,LIU Chun,ZHANG Juan.Clinical Observation of 95 Cases of Psoriasis Vulgaris of Blood Hot Air Drying Type Treated by Self Cooling Blood Runzao Decoction[J].The Chinese Journal of Dermatovenereology,2015,(07):853.[doi:10.13735/j.cjdv.1001-7089.201411143]
[2]隆岚,李振,钱振云,等.阿维A对寻常性银屑病患者CCL2和CCR2水平的影响[J].中国皮肤性病学杂志,2015,(10):1019.[doi:10.13735/j.cjdv.1001.7089.201503125]
 LONG Lan,LI Zhen,IAN Zhen yun,et al.Effects of Acitretin on CCL2 and CCR2 Levels in Patients with Psoriasis Vulgaris[J].The Chinese Journal of Dermatovenereology,2015,(07):1019.[doi:10.13735/j.cjdv.1001.7089.201503125]
[3]余晓玲,方凯,晋红中.寻常性银屑病合并良性型组织细胞吞噬性脂膜炎1例[J].中国皮肤性病学杂志,2015,(11):1167.[doi:10.13735/j.cjdv.1001-7089.201411001]
 YU Xiao ling,FANG Kai,JIN Hong zhong.A Case of Psoriasis Vulgaris Complicated with Benign Cytophagichistiocyticpanniculitis[J].The Chinese Journal of Dermatovenereology,2015,(07):1167.[doi:10.13735/j.cjdv.1001-7089.201411001]
[4]邢立亚,高丽琴,贾静,等.寻常性银屑病患者外周血单个核细胞肝脏X受体β的表达[J].中国皮肤性病学杂志,2016,(06):579.[doi:10.13735/j.cjdv.1001-7089.201511097]
 XING Li-ya,GAO Li-qin,JIA Jing,et al.Expression of Liver X Receptor β in Peripheral Blood Mononuclear Cells of Patients with Psoriasis Vulgaris[J].The Chinese Journal of Dermatovenereology,2016,(07):579.[doi:10.13735/j.cjdv.1001-7089.201511097]
[5]郭衡山,于雅洁,张小芳,等.寻常性银屑病合并大疱性类天疱疮1例[J].中国皮肤性病学杂志,2016,(06):607.[doi:10.13735/j.cjdv.1001-7089.201510081]
 GUO Heng-shan,YU Ya-jie,ZHANG Xiao-fang,et al.A Case of Coexistence of Psoriasis Vulgaris and Bullous Pemphigoid[J].The Chinese Journal of Dermatovenereology,2016,(07):607.[doi:10.13735/j.cjdv.1001-7089.201510081]
[6]刘爱民,崔利莎,张步鑫,等.麻防犀角地黄汤与犀角地黄汤治疗冬季血热型银屑病的疗效观察[J].中国皮肤性病学杂志,2016,(06):629.[doi:10.13735/j.cjdv.1001-7089.201510007]
 LIU Ai-min,CUI Li-sha,ZHANG Bu-xin,et al.Observation of Clinical Curative Effect of Mafang Xijiao Dihuang Decoction and Xijiao Dihuang Decoction in Treating Winter Psoriasis Vulgaris with Blood-Heat Syndrome[J].The Chinese Journal of Dermatovenereology,2016,(07):629.[doi:10.13735/j.cjdv.1001-7089.201510007]
[7]房婕,陈榕,刘莹,等.寻常性银屑病患者外周血髓源性抑制细胞的检测及其与Th17细胞的相关性[J].中国皮肤性病学杂志,2016,(09):902.[doi:10.13735/j.cjdv.1001-7089.201603008]
 FANG Jie,CHEN Rong,LIU Ying,et al.Detection of Myeloid-Derived Suppressor Cells in the Peripheral Blood of Patients with Psoriasis Vulgaris and its Correlation with Th17 Cells[J].The Chinese Journal of Dermatovenereology,2016,(07):902.[doi:10.13735/j.cjdv.1001-7089.201603008]
[8]王倩,刘伟,张丽霞,等.中性粒细胞/淋巴细胞比值与寻常性银屑病及银屑病关节炎的关系[J].中国皮肤性病学杂志,2016,(10):1017.[doi:10.13735/j.cjdv.1001-7089.201601143]
 WANG Qian,LIU Wei,ZHANG Li-xia,et al.The Relationship of Neutrophil to Lymphocyte Ratio with Psoriasis Vulgaris and Psoriasis Arthritis[J].The Chinese Journal of Dermatovenereology,2016,(07):1017.[doi:10.13735/j.cjdv.1001-7089.201601143]
[9]靳亚莉,张振国,乐宏元,等.寻常性银屑病患者血清中抗两种分枝杆菌LAM抗原抗体的检测[J].中国皮肤性病学杂志,2016,(11):1104.[doi:10.13735/j.cjdv.1001-7089.201604143]
 JIN Ya-li,ZHANG Zhen-guo,YUE Hong-yuan,et al.Detections of Antibodies Against Two Kinds of LAM Antigens of Mycobacteria in Serum from Patients with Psoriasis Vulgaris[J].The Chinese Journal of Dermatovenereology,2016,(07):1104.[doi:10.13735/j.cjdv.1001-7089.201604143]
[10]杨志波,唐雪勇,王畅.miR-199a抑制低氧诱导因子在银屑病患者皮损中的表达[J].中国皮肤性病学杂志,2017,(07):709.[doi:10.13735/j.cjdv.1001-7089.201611038]
 YANG Zhi-bo,TANG Xue-yong,WANG Chang.Role of miR-199a in Inhibiting the Expression of Hypoxia-inducible Factor in Psoriasis[J].The Chinese Journal of Dermatovenereology,2017,(07):709.[doi:10.13735/j.cjdv.1001-7089.201611038]

备注/Memo

备注/Memo:
[收稿日期] 2019- 10- 10 [修回日期] 2020- 02- 06
[基金项目] 广东省医学科研基金(A2016542); 广东省企业技术研发与省级改造专项资金项目(2013B021800044); 广东省医学科研基金(A2015305)
[通信作者] 罗权,E-mail:luoquan666@126.com.
[Corresponding author] LUO Quan,E-mail:luoquan666@126.com
更新日期/Last Update: 2020-07-01